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Abstract
Introduction: Patients with alcohol use disorders (AUD) are at increased risk of developing sepsis and have higher
mortality. AUD are associated with higher cortisol and anti-inflammatory cytokine profile. Higher cortisol increases
risk of death in septic patients. The relationship between AUD and cortisol in septic patients is unknown. We
aimed to study this relationship and postulated that AUD would be associated with higher cortisol and anti-
inflammatory cytokine profile.
Methods: This was a prospective cohort study of 40 medical intensive care unit (ICU) patients admitted with
sepsis. Cortisol, anti-inflammatory interleukin (IL) 10, and pro-inflammatory IL1b, IL6, tumor necrosis factor (TNF) a
were measured.
Results: Thirteen (32%) out of 40 patients had AUD. AUD patients had higher cortisol by univariate (39 microg/dl
versus 24, P = 0.04) and multivariable analyses (44 microg/dl versus 23, P = 0.004). By univariate analyses, AUD
patients had higher IL10 (198 picog/dl versus 47, P = 0.02) and IL6 (527 picog/ml versus 156, P = 0.048), but similar
IL1b and TNFa. By multivariable analyses, AUD patients had higher IL10 (182 picog/dl versus 23, P = 0.049) but
similar IL1b, IL6, and TNFa. AUD patients had lower IL1b/IL10 (univariate 0.01 versus 0.10, P = 0.04; multivariable
0.01 versus 0.03, P = 0.04), lower TNFa/IL10 (univariate 0.15 versus 0.52, P = 0.03; multivariable 0.11 versus 0.63, P =
0.01), but similar IL6/IL10.
Conclusions: AUD are common diagnoses among medical ICU patients with sepsis. Patients with AUD have
higher cortisol concentrations and have differences in cytokine expression. Future studies should seek to determine
if these differences may explain the higher severity of illness seen in patients with sepsis and AUD.
Trial registration: ClinicalTrials.gov: NCT00615862
Introduction
Patients with sepsis who have increased cortisol concen-
trations or poorer response to adrenocorticotropin hor-
mone (ACTH) stimulation have higher mortality than
those with normal cortisol and normal response to
ACTH [1-3]. Annane et al. found that cortisol >34
microg/dl was associated with a 2.4 higher odds of
death compared to ≤34 microg/dl [1]. Lipiner-Friedman
et al. also found that patients who died of sepsis had
higher cortisol compared to those who survived (29
microg/dl versus 24 microg/dl); patients who died also
had a lower incremental increase in cortisol in response
to ACTH administration (6 microg/dl versus 11 microg/
dl) [3]. It is unknown if impaired hypothalamic-pitui-
tary-adrenal (HPA) axis is a marker for increased risk of
death or the cause of increased mortality [2].
Alcohol use disorders (AUD) are common problems
worldwide [4]. In the United States, 7% of the popula-
tion has AUD, and among hospitalized patients, the rate
of AUD is estimated to be 21 to 42% [5-8]. Patients
with AUD are predisposed to developing sepsis, are
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any medium, provided the original work is properly cited.more likely to require mechanical ventilation, and have a
higher risk of death [9-12]. A number of studies have
demonstrated higher cortisol in surgical patients with
AUD, but not all studies support this finding [13-16].
Individuals with AUD who present for elective outpati-
ent detoxification also have higher cortisol compared to
individuals without AUD [17,18].
The reasons for the increased sepsis mortality in
patients with AUD may partly be explained by the effects
of alcohol on cytokine production. Patients with AUD
are known to have altered expression of pro-inflamma-
tory cytokines, including interleukin (IL) 6, tumor necro-
sis factor (TNF) a,a n dI L 1 b [14,16,19,20]. Similarly,
anti-inflammatory cytokine (IL10) production has been
found to be either elevated or decreased in surgical
patients with AUD [15,19]. Patients with AUD have been
shown to have a decreased ratio of pro-inflammatory to
anti-inflammatory cytokines, a finding that has been
linked to the development of nosocomial sepsis [14,19].
Recent studies also demonstrate a link between corti-
sol and immune function [21,22]. Activation of the HPA
axis is associated with immunosuppression, while down-
regulation of the axis improves immune function
[21,22]. We hypothesized that septic patients with AUD
compared to those without AUD might have differences
in cortisol and cytokine expression.
The relationship between cortisol and co-existing
AUD in critically ill patients with sepsis has not been
examined. We conducted an observational pilot study to
determine if septic patients with AUD would have
higher cortisol compared to septic patients without
AUD. We also hypothesized that septic patients with
AUD would have more depressed immune function as
measured by higher anti-inflammatory cytokine IL10
and lower ratio of pro-inflammatory cytokines (that is,
IL1b,I L 6 ,a n dT N F a) to anti-inflammatory cytokine
(that is, IL10). The results of this study have been pub-
lished in abstract format [23].
Materials and methods
Inclusion and exclusion criteria
All patients admitted to the medical ICU from the
Emergency Department were evaluated for study eligibil-
ity if they met criteria for sepsis as established by the
American College of Chest Physicians and Society of
Critical Care Medicine Consensus Conference [24].
Exclusion criteria were: age <18, pregnancy, prisoners,
no cortisol measured within 24 hours after Emergency
Department presentation, etomidate administration
prior to cortisol measurement, steroid administration
prior to measurement of cortisol, and inability to obtain
consent. Of note, no patient was diagnosed with alcohol
withdrawal during hospitalization; diagnosis of alcohol
withdrawal is based on clinical diagnosis and through
monitoring for withdrawal using the Clinical Institute
Withdrawal Assessment (CIWA-Ar) [25].
The Virginia Commonwealth University Human Investi-
gation Review Committee approved the study (HM11399)
and written informed consent was obtained from patients
or legally authorized representatives. To protect patients
from adverse consequences related to AUD diagnoses, we
also obtained a Certificate of Confidentiality from the
National Institutes of Health. The study was registered
with ClinicalTrials.gov (NCT00615862). The study was
conducted in accordance with the ethical standards of the
Declaration of Helsinki.
Definition of AUD
AUD was ascertained by administering a validated ques-
tionnaire to patients or legally authorized representatives
(in case patients were unable to respond). The Short
Michigan Alcohol Screening Test is a 13-item question-
naire that queries about adverse consequences of alcohol
consumption and has been successfully used by other
ICU investigators [10,26]. Patients who responded affir-
matively to ≥3 questions were considered to have AUD
(Table 1). Patients were classified into those with AUD
and those without AUD.
Cortisol concentrations
Cortisol as measured by the Virginia Commonwealth
University Medical Center Department of Pathology was
recorded. Quantification of cortisol before and one hour
after administration of 250 microg of ACTH was com-
pleted within the first 24 hours after Emergency Depart-
ment presentation. Delta cortisol (Δcortisol) was defined
Table 1 Short Michigan Alcohol Screening Test
An affirmative response to three or more questions is consistent with a
diagnosis of alcohol dependence.
1. Is your drinking a problem for you? (By problem we mean do you
drink more than other people.)
2. Does your wife, husband, a parent, or other near relative ever worry
or complain about your drinking?
3. Do you ever feel guilty about your drinking?
4. Do friends or relatives think you have a drinking problem?
5. Are you unable to stop drinking when you want to?
6. Have you ever attended a meeting of Alcoholics Anonymous (AA)?
7. Has your drinking ever created problems between you and your wife,
husband, a parent or other near relative?
8. Have you ever gotten into trouble at work because of your drinking?
9. Have you ever neglected your obligations, your family, or your work
for two or more days in a row because you were drinking?
10. Have you ever gone to anyone for help about your drinking?
11. Have you ever been in a hospital because of drinking?
12. Have you ever been arrested for drunken driving, driving while
intoxicated, or driving under the influence of alcoholic beverages?
13. Have you ever been arrested, even for a few hours, because of
other drunken behavior?
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ACTH administration. We defined cortisol as the base-
line cortisol (prior to ACTH administration). Cortisols
were tested in samples within one hour after collection
using the ADVIA Centaur cortisol assay (Bayer, Tarry-
town, NY, USA), which is a competitive immunoassay
using direct chemiluminescent technology.
Cytokine quantification
Investigators measured IL10, IL1b, IL6, and TNFa on the
serum sample from which the baseline cortisol was mea-
sured. If insufficient volume of serum remained, cyto-
kines were not measured. Patients did not have blood
drawn exclusively for study purposes. Samples were
stored at -80 degrees Celsius. Cytokines were measured
using Milliplex AP Assay which is based on the Luminex
xMAP technology (Millipore Corporation, Billierica, MA,
USA) and measures cytokines using antibody techniques.
Other variables
Demographics, infection site and type, mechanical venti-
lation characteristics, length of stay, and mortality were
also recorded. Severity of illness as measured by Acute
Physiology and Chronic Health Evaluation II (APACHE
II) and Sequential Organ Failure Assessment (SOFA)
were computed [27,28].
Data analysis
The primary endpoint of the study was the comparison
in baseline cortisol between the two groups of patients.
Because we expected different demographics between
the two groups (that is, demographics such as age, and
co-morbidities such as cirrhosis), we also adjusted for
between group characteristics when the P ≤ 0.25. Multi-
variable analysis using the standard least square was
performed and included all possible two-way interac-
tions. We set a = 0.05, and we did not adjust for multi-
ple comparisons in this pilot study.
Secondary outcomes were between group comparison
of Δcortisol, cytokines (IL10, IL1b,I L 6 ,a n dT N F a), and
pro-inflammatory to anti-inflammatory cytokine ratios
(IL1b/IL10, IL6/IL10, and TNFa/IL10).
A two-sided t-test was used when the outcome vari-
able was continuous after appropriate logarithmic con-
version when variables were not normally distributed.
Homogeneity of variance was found to be present using
t h eB r o w n - F o r s y t h et e s t .C h iS q u a r eT e s to rF i s h e r ’s
Exact Test was used when the outcome variable was
categorical. A log-rank test was used to compute
mechanical ventilation duration and ICU and hospital
lengths of stay.
Normally distributed data are reported as mean and
95% confidence interval (CI). Non-normally distributed
data are reported as median and interquartile range.
Sample size calculation
Spies et al. reported cortisol concentrations in surgical
patients with AUD [16]. Based on their data, the AUD
group had a mean cortisol one day after surgery of 750
nmol/l. We estimated that the group of patients without
AUD had a mean 250 nmol/l. We assumed the data
were lognormal since the mean was not symmetric
within the interquartile range, and we concluded that a
10% increase in cortisol between the patients without
and those with AUD would be clinically relevant. Con-
servatively, the interquartile range was ± standard devia-
tion. Thus the standard deviation was approximately
half the interquartile range. Assuming at least a 10%
increase in the mean cortisol in the group of patients
with AUD compared to the group without AUD, we
d e t e r m i n e dt h a tas a m p l es i z eo f4 0p a t i e n t si nt o t a l
would be associated with a 90% power at an a =0 . 0 5 .
Sample size calculation was performed using nQuery
Advisor (version 7.0, Statistical Solutions Ltd., Cork,
Ireland).
Results
Between July 2008, and May 2009, 137 patients were
admitted with a diagnosis of sepsis from the Emergency
Department. Thirty-four patients did not have cortisol
measured, 26 received etomidate, 21 received steroids
(either stress dose or were on chronic steroids), 10 were
prisoners, and 6 declined study participation.
Forty patients were enrolled, and 13 were diagnosed
with AUD (32%). All patients with AUD were actively
drinking at the time of hospital admission, and no patient
was diagnosed with alcohol withdrawal during their hos-
pitalization (that is, CIWA-Ar <10 in all cases). The
demographics of the cohort are detailed in Table 2.
Patients with AUD tended to be younger, tended to have
lower glucose concentrations, tended to have cirrhosis
more frequently, and tended to require vasopressor sup-
port more frequently; these four variables were included
in multivariable analyses. The lung was the most com-
mon site of infection. There was no difference between
the two groups in the need for and duration of mechani-
cal ventilation, lengths of stay, and mortality (Table 2).
By univariate analysis, patients with AUD had signifi-
cantly higher cortisol levels (Table 3). Multivariable ana-
lysis also demonstrated AUD was an independent
predictor of higher cortisol.
A total of 28 patients underwent quantification of
cytokines, 10 with AUD and 18 without AUD. By uni-
variate analyses, patients with AUD had higher IL10 and
IL6, but lower IL1b/IL10 and TNFa/IL10 (Table 3).
Multivariable analyses revealed that patients with AUD
had higher IL10, but lower IL1b/IL10 and TNFa/IL10.
The study was started after publication of the CORTI-
CUS trial, and only 15 patients underwent administration
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without AUD [29]. Because of this small number of
patients, the data are not reported in table format. By
univariate analysis, patients with AUD had a smaller
Δcortisol compared to the patients without AUD: 6
microg/dl, 95% CI (3.1; 10.5) versus 12 microg/dl, 95% CI
(8.0; 19.0), P = 0.04. Multivariable analysis demonstrated
that AUD was an independent predictor for lower Δcorti-
sol: Patients with AUD had a Δcortisol of 3 microg/dl,
95% CI (1.3; 6.0) versus 7 microg/dl, 95% CI (3.8; 12.4),
P = 0.01. When using a Δcortisol ≤9 microg/dl as a diag-
nostic cutoff of relative adrenal insufficiency, the two
groups had similar rates of relative adrenal insufficiency
by univariate analysis (4 out 5 patients with AUD versus
3 out of 10 patients without AUD, P = 0.06) and multi-
variable analysis (P = 0.08).
Discussion
In this prospective observational pilot study, we found
that a high proportion of patients with community
Table 2 Characteristics of the patients with and without alcohol use disorders (AUD)
AUD Present AUD Absent P
n1 3 2 7
Age * 47 (37.1; 56.3) 56 (49.8; 63.2) 0.10
Male (n, %) 7 (54%) 11 (41%) 0.44
Race (African American/white) (n, %) 8 (62%)/5 (38%) 16 (59%)/11 (41%) 0.89
APACHE II * 24 (18.3; 29.2) 22 (18.2; 25.8) 0.59
SOFA * 10 (7.1; 12.2) 8 (6.2; 10.0) 0.28
Vasopressor required within first 24 hours (n, %) 8 (62%) 9 (33%) 0.17
Glucose ** 110 (92.5; 128.0) 141 (105.0; 233.0) 0.06
Cirrhosis (n, %) 3 (23%) 2 (7%) 0.18
Hours after admission blood sample collected * 9 (3.5; 13.8) 11 (7.8; 14.9) 0.38
Site of infection (n, %) 0.98
Lung 7 (54%) 11 (41%)
Blood 2 (15%) 6 (22%)
Urinary tract 2 (15%) 5 (19%)
Gastrointestinal 1 (8%) 2 (7%)
Skin/soft tissue 1 (8%) 2 (7%)
Gynecologic 0 (0%) 1 (4%)
Bacteremia (n, %) 5 (38%) 11 (41%) 0.89
Gram positive organisms (n, %) 0.32
Staphylococcus aureus 1 (8%) 5 (19%)
Enterococcus species 0 (0%) 3 (11%)
Streptococcus pneumoniae 1 (8%) 1 (4%)
Other streptococcus species 1 (8%) 1 (4%)
Other staphylococcus species 0 (0%) 1 (4%)
Other gram positive organisms 1 (8%) 0 (0%)
Gram negative organisms (n, %) 0.83
Klebsiella pneumoniae 2 (15%) 3 (11%)
Pseudomonas species 0 (0%) 3 (11%)
Eschericia coli 1 (8%) 2 (7%)
Enterobacter species 0 (0%) 1 (4%)
Other gram negative organisms 0 (0%) 2 (7%)
Required mechanical ventilation (n, %) 8 (62%) 16 (59%) 0.89
Mechanical ventilation duration *** 4 (0.8; 5.4) 4 (1.1; 6.1) 0.59
ICU mortality 3 (23%) 5 (19%) 0.74
ICU length of stay ** 3 (1.0; 5.6) 5 (2.8; 7.8) 0.33
Hospital mortality 3 (23%) 5 (19%) 0.74
Hospital length of stay ** 8 (4.7; 16.0) 9 (6.2; 12.2) 0.82
* mean, 95% confidence interval.
** median, interquartile range.
AUD, alcohol use disorders; APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; ICU, Intensive Care Unit.
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of AUD are associated with higher cortisol concentra-
tions. In secondary analyses, we found that patients with
and without AUD had differences in cytokine expres-
sion. Patients with AUD had higher levels of the anti-
inflammatory cytokine IL10 but there was no difference
in pro-inflammatory cytokines IL1b,I L 6 ,a n dT N F a.
Patients with AUD had an anti-inflammatory cytokine
profile, as measured by depressed ratios of IL1b/IL10
and TNFa/IL10; however, the ratio of IL6/IL10 was
similar.
AUD have been associated with HPA dysfunction in
ambulatory individuals [17,18,30]. A majority of the lit-
erature finds that surgical ICU patients with AUD have
higher cortisol concentrations [13-16]. In our current
study, we similarly determined that septic patients with
co-diagnoses of AUD had higher cortisol: AUD was
associated with a 1.9-fold higher concentration by multi-
variable analysis. We do not believe the increased corti-
sol concentrations in patients with AUD were caused by
the development of alcohol withdrawal syndrome as no
patient was diagnosed with this complication during
hospitalization (as measured every four hours by CIWA-
Ar which is our standard of care).
Patients with AUD had similar pro-inflammatory cyto-
kines concentrations (IL1b,I L 6 ,a n dT N F a) but had
higher levels of anti-inflammatory cytokine IL10 com-
pared to patients without AUD (Table 3). These findings
are supported by other studies. Anti-inflammatory IL10
is elevated in the immediate post-operative period in
patients with AUD [15,19]. Studies examining surgical
patients have found conflicting results on the levels of
pro-inflammatory cytokine TNFa and IL1b [14]. IL6
levels in patients with AUD have been found to be simi-
lar, higher, or lower than patients without AUD
[14,15,19]. The increased IL10 concentration in patients
with AUD resulted in a lower ratio of IL1b/IL10 and
TNFa/IL10 but a similar ratio of IL6/IL10, findings
supported by other studies [14,19]. The differences
observed between our study results and other studies
may be explained by the timing of cytokine measure-
ment (within 24 hours of admission) and the patient
population studied. Other studies have examined post-
operative patients while our study evaluated medical
ICU patients admitted with sepsis.
The implications of this pilot study are that septic
medical ICU patients with AUD exhibit heightened
stress response and less robust immune response in the
setting of life threatening sepsis.
Our study has several limitations. Because we started
our study after publication of the CORTICUS study,
only 15 out of 40 patients underwent stimulation with
ACTH, and the small number of patients in whom
Δcortisol could be computed limits generalizability [3].
We also did not find a difference in mortality between
patients with and without AUD, but we did not power
our study to detect this difference. A larger study pow-
ered to detect mortality differences needs to be con-
ducted. In addition, we found an association between
AUD and cortisol and immune function, but the obser-
vational nature of our study does not permit determina-
tion of cause and effect. Cortisol and cytokine levels
were determined on one occasion and were not evalu-
ated longitudinally over time. In addition, we measured
cytokine concentrations only if sufficient serum volume
remained, leading to potential bias of test results: Two-
thirds of patients without AUD had cytokines measured
while three-quarter of patients with AUD had cytokines
quantified. In the acute phase of sepsis, cytokines
change over time. Our measurement at one point in
time does not fully reflect the interactions between
AUD and systemic inflammation. In this exploratory
study, we also did not adjust a for multiple analyses,
and future studies enrolling with adequate power and
enrolling larger number of patients need to be con-
ducted. Finally, only 29% of septic patients were enrolled
Table 3 Univariate and multivariable analyses of cortisol and cytokine concentrations in the two groups of patients
Univariate analysis Multivariable analysis**
AUD present AUD absent p AUD present AUD absent P
Cortisol (microg/dl) * 39 (27.0; 60.0) 24 (18.7; 31.4) 0.04 44 (31.0; 62.9) 23 (8.0; 29.1) 0.004
IL10 (picog/ml) * 198 (63.1; 621.5) 47 (20.1; 110.7) 0.02 182 (51.0; 646.4) 23 (6.8; 80.0) 0.049
IL6 (picog/ml) * 527 (154.6; 1794.2) 156 (72.0; 339.2) 0.048 641 (169.1; 2426.5) 137 (40.4; 465.1) 0.10
TNFa (picog/ml) * 30 (18.3; 50.4) 24 (17.0; 34.8) 0.23 44 (25.9; 74.9) 25 (15.9; 40.4) 0.06
IL1b (picog/ml) * 2 (0.4; 14.9) 6 (1.5; 21.1) 0.41 8 (1.1; 56.5) 3 (0.7; 14.7) 0.82
IL6/IL10 * 3.0 (1.27; 6.93) 4.9 (2.80; 8.67) 0.17 3 (1.2; 8.0) 8 (3.3; 19.5) 0.32
TNFa/IL10 * 0.15 (0.005; 0.437) 0.52 (0.240; 1.139) 0.03 0.11 (0.041; 0.292) 0.63 (0.307; 1.293) 0.01
IL1b/IL10 0.01 (0.001; 0.052) 0.10 (0.020; 0.530) 0.04 0.01 (0.001; 0.029) 0.03 (0.07; 0.104) 0.04
* mean, 95% confidence interval.
** Adjusted for age, glucose, cirrhosis, and vasopressor use.
AUD, alcohol use disorders; IL, interleukin; TNF, tumor necrosis factor.
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enrolled patients. It is possible that the enrolled patients
were qualitatively different from those not enrolled, and
that these difference may have impacted our results.
Conclusions
In conclusion, AUD are common co-diagnoses among
patients with sepsis, affecting approximately one-third of
patients. AUD are associated with higher cortisol concen-
trations and a different cytokine composition. Anti-
inflammatory cytokine IL10 is increased and the ratios of
IL1b/IL10 and TNFa/IL10 are lower in patients with
AUD, suggesting that AUD may be associated with
immunosuppression. Future studies should aim to deter-
mine if these differences may be the cause of higher mor-
bidity and mortality experienced by patients with AUD.
Key messages
￿ In septic medical ICU patients, patients with co-
existing AUD have higher cortisol concentrations
compared to patients without AUD.
￿ Septic patients with AUD have differences in cyto-
kine composition compared to septic patients with-
out AUD.
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